‘Ozempic drugs’ reduce obesity-associated cancer risk by up to 65% – New Atlas

Compared with insulin, GLP-1RAs were associated with a significantly lower risk for 10 of the 13 OACs: gallbladder cancer risk was reduced by 65%, …